Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

$FDA grants accelerated approval to zanubrutinib for relapsed or refractory follicular lymphoma$

FDA grants accelerated approval to zanubrutinib for relapsed or refractory follicular lymphoma

New insights into the growth and spread of cancer cells

New insights into the growth and spread of cancer cells

Transferring innovations in cancer treatment to other diseases

Transferring innovations in cancer treatment to other diseases

European treatment recommendations in the fight against acute lymphoblastic leukaemia

European treatment recommendations in the fight against acute lymphoblastic leukaemia

Scientists devise novel strategy to seek and destroy leukaemia stem cells

Scientists devise novel strategy to seek and destroy leukaemia stem cells

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

Elenagen, a novel DNA immunotherapy for the deadliest form of ovarian cancer, delays disease progression

Elenagen, a novel DNA immunotherapy for the deadliest form of ovarian cancer, delays disease progression

Researchers reveal mechanism of drug reactivating tumour suppressors

Researchers reveal mechanism of drug reactivating tumour suppressors

Research identifies air pollution’s role in childhood cancers — and how greenness might help mitigate it

Research identifies air pollution’s role in childhood cancers — and how greenness might help mitigate it

Cancer centre appoints prominent oncologist-researcher to lead transplantation and cellular therapy

Cancer centre appoints prominent oncologist-researcher to lead transplantation and cellular therapy

More from ecancer